Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Oncology (Williston Park) ; 37(3): 107-117, 2023 03 21.
Artigo em Inglês | MEDLINE | ID: mdl-36961958

RESUMO

BACKGROUND: Glioblastoma is the most common primary neoplasm of the central nervous system. Standard treatment includes surgery with maximum safe resection and radiotherapy plus concomitant and adjuvant chemotherapy; however, almost invariably, tumor relapse occurs. We aimed to describe signaling pathways and molecular mechanisms present in tumor relapse of glioblastoma. METHODS: This systematic review followed the PRISMA guidelines. We searched the PubMed, EMBASE and Web of Science databases. We included studies that enrolled patients 15 years or older with a diagnosis of glioblastoma according to Louis criteria and focused on signaling pathways and molecular mechanisms present in tumor relapse of glioblastoma. The outcome of interest was progression-free survival. RESULTS: We identified 1470 articles; 31 met the inclusion criteria. From each publication, we obtained the associated markers O-6-methylguanine-DNA methyltransferase, isocitrate dehydrogenase, mRNA, epidermal growth factor receptor (EGFR), p53, and others. All publications were evaluated with the Q-Genie checklist tool for quality assessment. CONCLUSIONS: We identified a wide variety of signaling pathways and molecular processes that are involved in glioblastoma relapse. This diversity would explain intra- and intertumor heterogeneity, treatment evasion, and relapse. However, only a few molecular processes have robust evidence for clinical utility.


Assuntos
Neoplasias Encefálicas , Glioblastoma , Humanos , Glioblastoma/genética , Glioblastoma/terapia , Neoplasias Encefálicas/terapia , Neoplasias Encefálicas/tratamento farmacológico , Quimioterapia Adjuvante , Recidiva , Transdução de Sinais
2.
J Neurol Surg Rep ; 83(4): e123-e128, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36467870

RESUMO

Background and Importance Brainstem lesions may be unresectable or unapproachable. Regardless, the histopathological diagnosis is fundamental to determine the most appropriate treatment. We present our experience with transfrontal stereotactic biopsy technique for brainstem lesions as a safe and effective surgical route even when contralateral transhemispheric approach is required for preservation of eloquent tissue. Clinical Presentation Twenty-five patients underwent surgery by transfrontal approach. Medical records were reviewed for establishing the number of patients who had postoperative histopathological diagnosis and postoperative complications. Twenty-four patients (18 adults and 7 children) had histopathological diagnosis. There were 18 astrocytomas documented, of which 12 were high grade and 6 low grade. The other diagnoses included viral encephalitis, post-renal transplant lymphoproliferative disorder, nonspecific chronic inflammation, Langerhans cell histiocytosis, and two metastases. No case was hindered by cerebrospinal fluid loss or ventricular entry. Complications included a case of mesencephalic hemorrhage with upper limb monoparesis and a case of a partially compromised third cranial nerve in another patient without associated bleeding. Conclusion Stereotactic biopsy of brainstem lesions by transfrontal ipsilateral or transfrontal transhemispheric contralateral approaches is a safe and effective surgical approach in achieving a histopathological diagnosis in both pediatric and adult populations.

3.
Rev. salud pública ; 14(6): 71-80, nov.-dic. 2012. ilus
Artigo em Espanhol | LILACS | ID: lil-703443

RESUMO

Objetivo La sífilis es una enfermedad infectocontagiosa, sistémica, de transmisión sexual causada por la espiroqueta Treponema pallidum. Las intervenciones que disminuyan la incidencia de la sífilis congénita contribuyen con dos de las metas de desarrollo del milenio (MDG). Existen métodos de diagnóstico y tratamiento para manejar la sífilis congénita, aunque, existen variaciones en seroprevalencia y el número de casos anuales mundialmente, la situación sigue siendo preocupante. El objetivo del estudio fue describir las disparidades por Departamentos en la incidencia de Sífilis congénita, en Colombia durante el período 2005 a 2011. Metodología Se tomaron los registros del sistema de vigilancia del Instituto Nacional de Salud (INS), y de nacidos vivos (NV) y necesidades básicas insatisfechas del Departamento Administrativo Nacional de Estadística-DANE de los años 2005 a 2011. Resultados En Colombia la Incidencia global aumento de 2,15 casos por 1 000 NV en el año 2005, (1 550 casos), hasta 3,28 Casos por 1 000 NV 2011 (2 078 casos), alejándose cada vez más de la MDG (0,5 por 1 000 NV). Conclusiones El número creciente de casos de Sífilis Congénita indica que sigue siendo un problema prioritario de salud pública, que el Sistema General de Seguridad Social en Salud no ha sido capaz de resolver, a pesar del aumento de cobertura y recursos que éste ha tenido en los últimos años, lo que exige una re-evaluación del impacto real que el Sistema ha tenido sobre los resultados en salud.


Objective Syphilis is a systemic, infecto-contagious, sexually-transmitted disease caused by the spirochete bacterium Treponema pallidum. Interventions reducing congenital syphilis incidence represent two of the Millennium Development Goals (MDG). Diagnostic and treatment methods are available for managing congenital syphilis; even so, variations occur in seroprevalence and the number of annual cases worldwide, so the situation continues to be worrying. This study was aimed at describing disparities per department regarding congenital syphilis incidence in Colombia from 2005 to 2011. Methodology Colombian Institute of Health (Instituto Nacional de Salud-INS) surveillance system records and Colombian Statistics Department (Departamento Administrativo Nacional de Estadística-DANE) records of live births (LB) and basic unsatisfied needs (BUN) from 2005 to 2011 were analyzed. Results Overall incidence in Colombia rose from 2.15 cases per 1,000 LB in 2005, (1,550 cases) to 3.28 cases per 1,000 LB in 2011 (2,078 cases), thereby moving further away from the MDG (0.5 per 1,000 LB). Conclusions The growing number of cases of congenital syphilis indicates that this continues being a priority problem for public health and that the Overall Healthcare-related Social Security System (OHSSS) has not been able to resolve it, in spite of increased coverage and the resources which this entity has received during the last few years. Such situation demands a re-evaluation of the OHSSS's real impact on public healthcare results.


Assuntos
Humanos , Recém-Nascido , Disparidades nos Níveis de Saúde , Sífilis Congênita/epidemiologia , Colômbia/epidemiologia , Incidência , Fatores de Tempo
4.
Rev Salud Publica (Bogota) ; 14(6): 968-81, 2012 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-24892437

RESUMO

OBJECTIVE: Syphilis is a systemic, infecto-contagious, sexually-transmitted disease caused by the spirochete bacterium Treponema pallidum. Interventions reducing congenital syphilis incidence represent two of the Millennium Development Goals (MDG). Diagnostic and treatment methods are available for managing congenital syphilis; even so, variations occur in seroprevalence and the number of annual cases worldwide, so the situation continues to be worrying. This study was aimed at describing disparities per department regarding congenital syphilis incidence in Colombia from 2005 to 2011. METHODOLOGY: Colombian Institute of Health (Instituto Nacional de Salud-INS) surveillance system records and Colombian Statistics Department (Departamento Administrativo Nacional de Estadística-DANE) records of live births (LB) and basic unsatisfied needs (BUN) from 2005 to 2011 were analyzed. Results Overall incidence in Colombia rose from 2.15 cases per 1,000 LB in 2005, (1,550 cases) to 3.28 cases per 1,000 LB in 2011 (2,078 cases), thereby moving further away from the MDG (0.5 per 1,000 LB). CONCLUSIONS: The growing number of cases of congenital syphilis indicates that this continues being a priority problem for public health and that the Overall Healthcare-related Social Security System (OHSSS) has not been able to resolve it, in spite of increased coverage and the resources which this entity has received during the last few years. Such situation demands a re-evaluation of the OHSSS's real impact on public healthcare results.


Assuntos
Disparidades nos Níveis de Saúde , Sífilis Congênita/epidemiologia , Colômbia/epidemiologia , Humanos , Incidência , Recém-Nascido , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...